Johnson & Johnson JNJ

$257.78 -1.58 (-0.61%)

Valuation

Market cap
611,608,000,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
24.00
Forward PE
22.99
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
6,557,000
Avg volume
6,832,706
Day's range
$254.56 – $257.80
Shares out
2,409,898,000
Stochastic %K
74%
Beta
0.21
Analysts
Strong Sell
Price target
$282.24

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

Honest_Abe Oct 21, 11:53 PM
$PFE $JNJ $SPY $QQQ You know who doesn’t have blood clots? Aaron Rodgers.
1 replies
SellasgpsCurativeBAT11 Oct 21, 11:20 PM
$SLS $JNJ $AZN $PFE $ABBV Sellas has Booth than Seagen= $50 Billy. Keep it simple. Like they say keep it simple stupid. We will skip moon on this trip! ✌️🙏❤️‍🩹
0 replies
Mr_Anderson007 Oct 21, 10:07 PM
$JNJ $SLS The higher their share price the more currency they have. Whoever acquires SLS will almost immediately start 5-10 new trials for each asset if not more.
2 replies
bikechain Oct 21, 10:03 PM
$JNJ $SLS I wouldn’t mind a 1:1 all stock BO.😅
1 replies
Strigiform Oct 21, 9:48 PM
$SLS TD Cowen raised $JNJ price target to $300? When people say “somebody knows something” this is who they mean. 
0 replies
chursinow62 Oct 21, 9:38 PM
$JNJ Indiders loading up on huge headlines
0 replies
chursinow62 Oct 21, 9:37 PM
$JNJ Load🚀🚀🚀 people
0 replies
BarkingPuppy Oct 21, 6:59 PM
$ELTP $GME $JNJ $BTC.X This will be the 2027 Meme coin!!! Lots of insider buying!! What does that tell you?? Oct 19, 2026 4 Statement of Changes in Beneficial Ownership View this form 4 on SEC.gov for Dash Barry H
0 replies